The SpaceBears ransomware group claims to have breached AbelZeta Pharma (AbelZeta), a global clinical-stage biopharmaceutical company and cell therapy leader focused on discovering and manufacturing therapeutics for hematologic malignancies, solid tumors, and inflammatory diseases.
The allegedly compromised data includes:
-
170,000+ confidential files
-
670+ separate archives containing experiments on various drug candidates
-
Confidential studies and competitive research related to CAR032, CAR39, CAR66, CAR168, TIL, CD, and Tcell
-
Documentation potentially related to prominent partners (AstraZeneca, Janssen, Novartis) and investors (HSG, Yunfeng Capital, GIC, TF Capital, and others)












